English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Metformin has been used for over 40 years for patients with type 2 diabetes mellitus.[1][1] With over 40 million patient-years of use as of 1999,[1][1] there is now evidence that the drug decreases the risk of morbidity and death when used to treat type 2 diabetes.[2][2] However, concern remains

Metformin's contraindications should be contraindicated